CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,754 | -51.2% | 175,600 | -37.2% | 0.00% | -42.9% |
| Q2 2023 | $313,152 | +3.3% | 279,600 | -4.1% | 0.01% | -12.5% |
| Q1 2023 | $303,264 | -14.5% | 291,600 | -7.9% | 0.01% | -11.1% |
| Q4 2022 | $354,592 | -1.0% | 316,600 | 0.0% | 0.01% | -10.0% |
| Q3 2022 | $358,000 | -23.0% | 316,600 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $465,000 | -35.9% | 316,600 | 0.0% | 0.01% | -21.4% |
| Q1 2022 | $725,000 | -16.8% | 316,600 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $871,000 | -54.2% | 316,600 | 0.0% | 0.02% | -55.6% |
| Q3 2021 | $1,900,000 | +23.2% | 316,600 | 0.0% | 0.04% | +28.6% |
| Q2 2021 | $1,542,000 | +125.8% | 316,600 | +14.5% | 0.03% | +115.4% |
| Q1 2021 | $683,000 | +35.5% | 276,600 | +50.3% | 0.01% | +18.2% |
| Q4 2020 | $504,000 | +78.1% | 184,000 | 0.0% | 0.01% | +83.3% |
| Q3 2020 | $283,000 | -18.2% | 184,000 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $346,000 | +126.1% | 184,000 | +104.4% | 0.01% | +75.0% |
| Q1 2020 | $153,000 | -41.4% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $261,000 | +357.9% | 90,000 | 0.0% | 0.00% | +300.0% |
| Q3 2019 | $57,000 | -34.5% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $87,000 | -29.8% | 90,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $124,000 | -16.8% | 90,000 | -35.3% | 0.00% | 0.0% |
| Q4 2018 | $149,000 | -82.6% | 139,200 | 0.0% | 0.00% | -75.0% |
| Q3 2018 | $856,000 | +7.9% | 139,200 | +87.6% | 0.01% | 0.0% |
| Q2 2018 | $793,000 | -34.1% | 74,200 | -33.8% | 0.01% | -38.5% |
| Q1 2018 | $1,203,000 | +53.2% | 112,100 | 0.0% | 0.01% | +62.5% |
| Q4 2017 | $785,000 | -19.9% | 112,100 | 0.0% | 0.01% | -27.3% |
| Q3 2017 | $980,000 | -4.0% | 112,100 | 0.0% | 0.01% | -8.3% |
| Q2 2017 | $1,021,000 | +157.2% | 112,100 | +124.2% | 0.01% | +140.0% |
| Q1 2017 | $397,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |